Serum protease inhibitor - Ulinastatin in the complex therapy of severe acute pancreatitis complicated by sepsis
Main Article Content
Abstract
Acute pancreatitis is an acute inflammation of the pancreas that often leads to pancreatic necrosis and is the cause of death in 40% to 70% of patients. [1] Given the severity of this disease and the insufficient effectiveness of generally accepted methods of treatment, we studied the effectiveness of the drug Ulinastatin (serum protease inhibitor) in the complex therapy of acute pancreatic necrosis, complicated by diffuse purulent peritonitis and sepsis.
Article Details
How to Cite
Avakov V.E, Ibrahimov N.K, Gaziev Z.T, Ramazanova Z.F, Muralimova R.S, & Murotov TMN. (2022). Serum protease inhibitor - Ulinastatin in the complex therapy of severe acute pancreatitis complicated by sepsis. Eurasian Research Bulletin, 15, 140–148. Retrieved from https://geniusjournals.org/index.php/erb/article/view/2854
Issue
Section
Articles